110
Participants
Start Date
November 13, 2024
Primary Completion Date
April 30, 2027
Study Completion Date
April 30, 2027
Peking University People'S Hospital /ID# 274505, Beijing
The First Affiliated Hospital of Dalian Medical University /ID# 270563, Dalian
Shanghai General hospital /ID# 270376, Shanghai
Qingdao Eye Hospital Of Shandong First Medical University /ID# 268173, Qingdao
The Second Affiliated Hospital of Zhejiang University School of Medicine /ID# 273617, Hangzhou
The Affiliated Eye Hospital Of Wenzhou Medical University /ID# 274466, Wenzhou
Xiamen Eye Center of Xiamen University /ID# 268172, Xiamen
General Hospital of Central Theater Command /ID# 273618, Wuhan
Henan Provincial Eye Hosptial /ID# 272424, Zhengzhou
Zhongshan Ophthalmic Center,SunYat-Sen University /ID# 274555, Guangzhou
West China Hospital of Sichuan University /ID# 273656, Chengdu
Xi'an Fourth Hospital /ID# 270562, Xi'an
Shanxi Eye Hospital /ID# 270564, Taiyuan
Lead Sponsor
AbbVie
INDUSTRY